REVIEW
|
doi:10.20944/preprints202404.1071.v1
Subject:
Medicine And Pharmacology,
Internal Medicine
Keywords:
COVID-19; SARS-CoV-2; DMARDs; immunocompromised; immune-mediated inflammatory disease; rheumatic disease
Online: 16 April 2024 (17:29:36 CEST)